Summary.-The i.v. administration of Corynebacterium parvum (CP) to patients who had recently undergone resection of colorectal tumours was found to have the following effects:
THE SUCCESS of Corynebacterium parvunt (CP) in suppressing the growth of animal tumours (Scott, 1974) has led to the evaluation of its role as an immunotherapeutic agent in human malignancy. The investigation of the effects of this agent on human immune reactions is of obvious importance for understanding its effects on patients, and to assist rational scheduling of immunotherapy. There are few reports of systematic studies of such effects of CP in healthy patients not receiving any other treatment in the form of chemotherapy or radiotherapy.
The study reported here involved patients whose only previous treatment had been tumour resection, and who were in good health and clinically free of tumour. In view of the suppression of lymphocyte function by CP which has been reported in animal systems (Scott, 1 972a; Allwood & Asherson, 1973) monitoring of lymphocyte function during and after treatment was considered clinically desirable as well as scientifically important.
PATIENTS AND) METHOI)S
The patients consisted of 11 re cently diagnosed cases of carcinoma of the rectum who had undergone potentially curative resection of their tumours within the 30 days preceding immunotherapy. They had all made a satisfactory recovery and were readmitted for their first infusion of CP, on which the work described in the present study is based. Immnu)otherapy. Corynebacterium parvurm (Welleome Laboratories, Beckenham, Kent) 5 mg/M2 was administered i.v. over 1 h in normal saline, and vital signs were monitored hourly for 24 h. The i.v. route wNas chosen on the basis of experimental observation that this produced a greater anti-tumour effect than s.c. administration (Castro, 1977 dose used had been previously reported to be associated with mild clinical consequences in Phase I studies (Reed et al., 1975) .
Blood counts. Differential white cell and platelet counts were made in the Haematology Laboratory of the Nuffield Department of Medicine. For monocyte counts, smears were stained as described by Yam et al. (1971) .
Cytotoxicity assays. A whole-blood method was used Waller & MacLennan, 1977; Waller et al., 1976) .
Mitotic response to PHA.-A whole-blood method was used (Maini et al., 1973) . Heparinized blood was diluted wkith MEM+ 100% FCS + 20 units preservative-free heparin per ml.
Diluted blood (500 1d) was added to 3 sets of triplicate 72 x 12mm tubes. PHA (Welleome, reagent grade) was added in 500 jul of medium to final concentrations of 0, 1:1000 and 3:1000. The tubes were tightly stoppered and incubated for 68 h, when 1 ,uCi of 3H-thymidine (Radiochemical Centre, Amersham) was added. Cultures were harvested at 72 h and the ct/min in the trichloroacetic acid-precipitated residues measured with a Beckman counter. Results are expressed as logio (ct/min in stimulated cultures ct/min in unstimulated cultures).
Serum lysozyrne. This was estimated on serum samples using the lyso-plate method of Osserman & Lawlar (1966) . Statistical methods-.The significance of changes in lymphocyte number and function before and after immunotherapy was estimated using the t test for paired data.
RESULTS
The nmean values for all assays at the various times are showiv in the Table. Leucocyte counts
The changes following a single infusion are depicted in Fig. 1 . The increase in polymorphonuclear leucocytes at 24 h is significant (P<O0001) and large numbers (19-360o) of the myeloid series in the blood at this time are juvenile forms.
All patients showed a decrease in lymphocyte count during the first 24 h (0 005 >P> 0.001). The reduction in the numbers of esterase-positive cells was more dramatic (P < 0 001) and this initial reduction was followed by an increase at 783s Mitogenic response to PHA There was a reduction in the mitotic response to PHA at 3 and 24 h after CP administration (Fig. 2) . In the case of the suboptimal stimulating dose of PHA, significant suppression was observed at both times (0.005 > P> 000 Iand P < 000I respectively). At the optimal dose of PHA, significant suppression was present only at 24 h (P < 0001). Lymphocyte cytotoxicity against Chang cells
The changes in cytotoxic activity following CP administration are shown in . in all 3 assays, 3 h after infusion (P < 0 001 ). There was some recovery at 24 h, and subsequently a slight increase above the initial values was seen at 7 days. This increase was significant only for antibodyand PHA-induced cytotoxicity (P < 0.025). 28 days after the infusion, the levels of cytotoxicity were not significantly different from the initial values.
Serum lysozyme This enzyme was measured because it is present in cells of the macrophage series and because it has been suggested that it may be one index of macrophage-mediated resistance to tumour in humans (Currie, 1976) . Increased levels were recorded at 3 and 24 h after CP was given, and these increases were statistically significant (P < 0a002 and P < 0a02 respectively). The levels were, however, beginning to fall in some patients by 24 h, and these increases were not subsequently maintained (Fig. 5) . (Gill et al., 1977a) and those reported by other workers (Minton et al., 1976 be involved in this response (Oppenheim et al., 1968; Potter & Moore, 1977) . However, the fall in antibody-and PHAinduced lymphocytotoxicity 3 h after CP infusion is considerably greater than could be expected from the drop in lvmphocyte counts alone. The i.v. administration of prednisolone produces a nonsynchronous pattern of loss of lymphocytes and their cytotoxicity similar to that found here. However, the maximal depression of antibody-induced cytotoxicity by steroids occurs 20 h after the lowest lymphocyte count. Although a further loss of cytotoxicity may have occurred 48 h after CP administration, the first significant fall, which was measured at 4 h, cannot be ascribed to the effect of endogenous steroids. A more likely explanation is that K cells are temporarily blocked by circulating products resulting from the infusion, such as antigen-antibody complexes formed between the bacteria and the natural antibodies which are present in these patients. All the patients studied were receiving their first infusion, and a low level of such antibodies might be expected. However, K cells have been shown to be very sensitive to the blocking action of such complexes (MacLennan, 1972) . Fibrinogen degradation products can also interfere with the expression of lymphocyte responses in vitro (Ginmann et al., 1976) and these products are markedly elevated 3 h after infusion of CP (Cederholm-Williams et al., 1978) when the mitogenic and cytotoxicity responses were reduced. Further experiments using isolated lymphocytes are clearly required to determine whether alterations in lymphocyte subpopulations or serum factors are responsible for these changes. Thatcher & Crowther (1978) have demonstrated an initial fall followed by a rise in cytotoxicity after CP, but differences in the time at which samples were assayed and in the methods of quantitating cytotoxicity make direct comparisons with their results difficult. Similar considerations apply to related studies in cancer patients (Webster et al., 1978) in whom the mitogenic response to PHIA was found to be unchanged.
The clinical relevance of the suppression of lymphocyte cytotoxic and mitogenic activities during the 24 h after CP treatment is uncertain, but it is of interest in this regard that there was a significant incidence of herpetic and varicelliform eruptions in these patients within 24-36 h of infusion (Gill et al., 1 977b) . One potentially important practical point which stems from these findings concerns the scheduling of CP in clinical protocols. It would seem desirable to design the frequency of CP therapy in order to allow immunological recovery between treatments, though further studies of such protocols would be required to confirm this suggestion.
The effect of the monocyte series needs comment, since it has been suggested in several animal tumour svstems that CP produces its anti-tumour effects by increasing both macrophage numbers (Baum & Fisher, 1972; Wolmark & Fisher, 1974) and phagocytic function (Scott, 1972b) . The rapid reduction in monocyte nuimber immediately after infusion is similar to the findings of other workers (Minton et al., 1976) but we also observed a significant increase 7 days later.
There were also qualitative differences between the cells of the monocyte series observed at these times, those present 24 h after treatment being smaller and with fewer esterase-positive granules than those present at 7 days. This, together with the subsequent increase in numbers, is in accord with a stimulatory effect of CP on marrow which has been documented in mice Foster, 1978) and rats (Wolmark & Fisher, 1974) . The timing of these changes closely parallel those observed in mice, in which increased plasma levels of marrow colony-stimulating factor were detected within hours of CP injection (Foster, 1978; Eliopoulos et al., 1978) . Considered in conjunction with the acute suppression and recovery in lymphocyte function, the increased monocyte numbers after 7 days suggest that one rational schedule for CP therapy might be infusions at 1-2-weekly intervals, rather than the monthly schedule which is currently widely used clinically. This suggestion would require confirmation by further studies, but Hedley et al. (1979) have recently published data on monocyte function which also suggest that administration more often than every 4 weeks may be more appropriate in humans. These workers also demonstrated increased monocyte function using small intradermal doses of CP. The increase in serum lysozyme levels was significant, but transient. This enzyme is present in both polymorphs and macrophages, but recent clinical and experimental studies have proposed that its measurement provides one parameter of macrophage-mediated defence against tumours (Currie, 1976) . Its infusion does not follow the change in numbers of monocytes, and the changes observed probably represent the rapid release from mature cells of the granulocyte and macrophage series. The increase in lysozyme does, however, closely parallel the enormous increase in fibrinolytic activity which we have observed in these patients (Cederholm-Williams et al., 1978) and it is interesting to note that both lysozyme and plasminogen activators are important secretory products of macrophages (Gordon, 1976 ).
Although we have demonstrated consistent transient suppression of lymphocyte function in the blood of these patients immediately after infusion, this should not necessarily be regarded as a contraindication to such immunotherapy. We take this view because of the rapid recovery which occurs; because no sustained immunosuppression was demonstrable in patients who had had multiple infusions (Waller et al., 1980) ; and because in animal tumour systems CP still exerts its anti-tumour effect, despite concomitant immunosuppression.
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